ABC2-Funded Research Featured in Scientific American
Article | January 31, 2022
Brain cancer research funded by Accelerate Brain Cancer Cure is featured in Scientific American today.
The research involves a multi-center clinical study using new exosomal diagnostic tests developed by New York City-based Exosome Diagnostics to identify a genetic mutation found exclusively in glioma, the most common form of brain cancer.
Brain tumor cells shed micro-vesicles, called exosomes, into cerebral spinal fluid, blood, and urine. This new method of testing could potentially detect and monitor the progression of a wide variety of cancers and eliminate the need for painful and sometimes life-threatening biopsies.